Placental and maternal serum inhibin-A and activin-A levels in Down's syndrome pregnancies

Placenta

Volumn 22, Issue 2-3, 2001, Pages 227-234

  Dalgliesh, G L ^a   Aitken, D A ^a   Lyall, F ^a   Howatson, A G ^a   Connor, J M ^a  

^a NHS GREATER GLASGOW AND CLYDE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN A; INHIBIN A; PLACENTA EXTRACT; PROTEIN SUBUNIT;

ALPHA CHAIN; ARTICLE; BETA CHAIN; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DOWN SYNDROME; FEMALE; FETUS; GESTATIONAL AGE; HORMONE BLOOD LEVEL; HORMONE SYNTHESIS; HUMAN; HYPOTHESIS; IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MATERNAL BLOOD; PLACENTA; PLACENTA VILLUS; PREGNANCY; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STROMA; TISSUE SECTION; TROPHOBLAST;

EID: 0034970746     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1053/plac.2000.0598     Document Type: Article

References (39)

1. Dimeric inhibin-A as a marker for Down's syndrome in early pregnancy
2. Abnormal maternal serum chorionic gonadotrophin levels in pregnancies with fetal chromosome abnormalities
3. Maternal serum dimeric inhibin A in second-trimester Down's syndrome pregnancies
4. Maternal serum activin A and follistatin levels in pregnancies with Down's syndrome
5. Detection of dimeric inhibin throughout the human menstrual cycle by two-site enzyme immunoassay
6. Immunoassays for inhibin and its subunits. Further applications of the synthetic peptide approach
7. Regulatory functions for inhibin and activin in human ovaries
8. The TGF-beta superfamily: New members, new receptors, and new genetic tests of function in different organisms
9. Roles of inhibins, activins, and follistatin in the female reproductive system
10. Development and application of a two-site enzyme immunoassay for the determination of 'total' activin-A concentrations in serum and follicular fluid
11. Second trimester levels of maternal serum inhibin-A, total inhibin, a inhibin precursor, and activin in Down's syndrome pregnancy
12. Maternal serum total activin A in pregnancies affected with fetal Down's syndrome
13. Second trimester levels of maternal serum total activin A and placental inhibin/activin alpha and betaA subunit messenger ribonucleic acids in Down syndrome pregnancy
14. Protein measurement with the Folin phenol reagent
15. Localization of the cellular expression of inhibin in trophoblastic tissue
16. Inhibin suppresses human chorionic gonadotropin secretion in term, but not first trimester, placenta
17. Immunohisochemical localization of inhibin/activin subunits in human placenta
18. Serum concentrations of dimeric inhibin during the spontaneous human menstrual cycle and after treatment with exogenous gonadotrophin
19. Inverse effects of activin and inhibin on the synthesis and secretion of FSH and LH by ovine pituitary cells in vitro
20. Biochemical markers of trisomy 21 and the pathophysiology of Down's syndrome pregnancies
21. Inhibin, activin and follistatin in the human placenta-a new family of regulatory proteins
22. Inhibin subunits in human placenta: Localization and messenger ribonucleic acid levels during pregnancy
23. Gonadotropin-releasing hormone, inhibin, and activin in human placenta: Evidence for a common cellular localization
24. Hypertension in pregnancy: Changes in activin A maternal serum concentration
25. Abnormal concentration of maternal serum activin-A in gestational diseases
26. Increased midtrimester amniotic fluid activin-A: A risk factor for subsequent fetal death
27. Regulation of inhibin secretion in human placental cell culture by epidermal growth factor, transforming growth factors, and activin
28. Inhibin and activin production in human placenta
29. Circulating bioactive inhibin levels during human pregnancy
30. Localization and regulation of the activin-A dimer in human placental cells
31. Isolation of inhibin from bovine follicular fluid
32. Activin-A stimulates, while transforming growth factor beta 1 inhibits, chorionic gonadotrophin production and aromatase activity in cultured human placental trophoblasts
33. Acute stimulation of human chorionic gonadotropin secretion by recombinant human activin-A in first trimester human trophoblast
34. Purification and characterization of an FSH releasing protein from porcine ovarian follicular fluid
35. Prenatal screening for Down's syndrome using inhibin-A as a serum marker
36. Inhibins and activins: Roles in clinical practice
37. Second trimester screening for Down's syndrome using maternal serum dimeric inhibin A
38. Amniotic fluid inhibin-A in chromosomally normal and Down's syndrome pregnancies
39. Comparison of functional response of rat, macaque, and human ovarian cells in hormonally defined medium